Aarti Drugs Ltd (BOM:524348)
₹ 490.15 -5.35 (-1.08%) Market Cap: 44.74 Bil Enterprise Value: 50.34 Bil PE Ratio: 29.56 PB Ratio: 3.50 GF Score: 92/100

Q1 2021 Aarti Drugs Ltd Earnings Call Transcript

Jul 27, 2020 / NTS GMT
Release Date Price: ₹436.79 (+9.87%)
Operator

Over to Ms. Cyndrella Carvalho, from Centrum Broking Limited. Thank you and over to you ma'am.

Cyndrella Carvalho
Centrum Broking Limited - Analyst

Thank you, Janice. Good afternoon, everyone. On behalf of Centrum team, I Cyndrella Carvalho, thank the Aarti Drugs management team for giving us this opportunity to host this quarter one, FY21 earnings con call. From Aarti Drug management team, we have with us today Mr. Harit Shah, Whole-Time Director; Mr. Adhish Patil, Chief Financial Officer; Mr. Vishwa Savla, Director, Pinnacle Life Sciences. At the outset, I congratulate the management team on delivering excellent earnings in these unprecedented times, and I now hand over the con call to Mr. Adhish for their opening remarks.

Adhish Patil
Aarti Drugs Limited - CFO

Hi. Good afternoon all, thank you for joining the conference call of Aarti Drugs Limited. Management welcomes you all. Main purpose of the call is to brief you about the quarterly performance of the company and the current market conditions for the business.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot